HighMark Wealth Management »

Xenon Pharmaceuticals shares owned by HighMark Wealth Management

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by HighMark Wealth Management from 13F filings

Historical chart of HighMark Wealth Management investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by HighMark Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by HighMark Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.0M 26k 40.15
2025-06-30 $817k 26k 31.30
2025-03-31 $205k 6.1k 33.55
2024-12-31 $239k 6.1k 39.20
2024-09-30 $197k 5.0k 39.37
2024-06-30 $195k 5.0k 38.99
2024-03-31 $215k 5.0k 43.05

More positions owned by HighMark Wealth Management

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p Us Vlu (IUSV)
Wells Fargo & Company (WFC)
Performant Finl (PHLT)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Anaptysbio Inc Common (ANAB)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Ishares Tr Core S&p Mcp Etf (IJH)
Axogen (AXGN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Neogenomics Com New (NEO)

View all positions for HighMark Wealth Management

Top funds holding Xenon Pharmaceuticals

FMR
venBio Select Advisor
BlackRock
Driehaus Capital Management
Henderson Group
Wellington Management Company
Braidwell
Capital Research and Management Company - Division 3
Commodore Capital
Polar Capital Holdings
Holocene Advisors
Alliancebernstein
State Street Corporation
Millennium Management
Affinity Asset Advisors

View all funds holding Xenon Pharmaceuticals